Nj State Employees Deferred Compensation Plan Amicus Therapeutics, Inc. Transaction History
Nj State Employees Deferred Compensation Plan
- $824 Million
- Q3 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 17,000 shares of FOLD stock, worth $159,970. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,000
Previous 17,000
-0.0%
Holding current value
$159,970
Previous $168,000
7.74%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
314MCall Options Held
516KPut Options Held
833K-
Vanguard Group Inc Valley Forge, PA28.8MShares$271 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$264 Million7.83% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$229 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$226 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$218 Million3.72% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.64B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...